Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bringing leaders together to support the development of children's palliative care across the Asia Pacific region-an interdisciplinary workshop.

Ecancermedicalscience·2026
Same author

Narrative Quotient: A Core Competency for Person-Centered Care.

Medical science educator·2026
Same author

Milestones and Horizons: Highlights from the 4th International Children's Palliative Care Network Conference in Manila, Philippines.

Ecancermedicalscience·2026
Same author

Interventions Addressing Acculturative Stress in Latinx Immigrants Residing in the US: An Evidence Map.

Translational issues in psychological science·2026
Same author

Neurocognitive functioning of patients with sickle cell disease in low- and middle-income countries.

Blood global hematology·2026
Same author

Physician Perceptions Toward Palliative Care Integration in Childhood Cancer Care in Asia Pacific.

JCO global oncology·2026

Related Experiment Video

Updated: Jun 14, 2026

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
07:11

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling

Published on: February 5, 2019

9.1K

Pediatric Palliative Care Program Implementation in LMICs: A Systematic Review using SWOT Analysis.

Sarah Ann Kenneson1, Alexzandra Hughes-Visentin2, Jordan Wrigley3

  • 1College of Medicine (S.A.K., D.M.), University of Tennessee Health Science Center, Memphis, Tennessee, USA.

Journal of Pain and Symptom Management
|July 6, 2023
PubMed
Summary

Pediatric palliative care (PPC) programs are being implemented in low-resource settings, but access remains limited. Sharing successes and challenges is crucial for expanding essential PPC initiatives globally.

Keywords:
Pediatricimplementationlow- and middle-income countries (LMIC)palliative caresystematic review, SWOT analysis

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.1K
Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

3.8K

Related Experiment Videos

Last Updated: Jun 14, 2026

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
07:11

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling

Published on: February 5, 2019

9.1K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.1K
Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

3.8K

Area of Science:

  • Global Health
  • Palliative Care Medicine

Background:

  • An estimated 21 million children worldwide require pediatric palliative care (PPC), with 97% residing in low- and middle-income countries (LMIC).
  • Access to and implementation strategies for PPC programs in LMIC remain understudied.

Approach:

  • A systematic review following PRISMA guidelines was conducted to analyze the strengths, weaknesses, opportunities, and threats (SWOT) of PPC program implementation in LMIC.
  • Searches of key databases and manual reference reviews identified 78 relevant items describing 82 unique PPC programs across various income-level countries.

Key Points:

  • Common strengths include multidisciplinary teams and psychosocial support.
  • Weaknesses identified were a lack of PPC training and research infrastructure.
  • Opportunities involve inter-institutional collaboration and government support, while threats include limited access to services and medications.

Conclusions:

  • Pediatric palliative care programs can be successfully implemented in resource-limited settings.
  • Hospice and palliative medicine organizations should encourage clinicians to disseminate detailed program implementation successes and challenges to foster growth in LMIC.